Concepedia

Johnny Roy

JR

Statistics

Publications

7

Citations

750

H-Index

7

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Oklahoma Health Sciences Center

Mayo Clinic

WinnMed

Telemark Hospital

Johnny Roy is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, urology, and prostate disease.

Publications per year

1995–2003

7

Publications

7

SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIA

Claus G. Roehrborn, John D. McConnell, JAIME BONILLA et al. · The Journal of Urology · 2000 · 268 citations

, , +16

Doxazosin for the Treatment of Benign Prostatic Hyperplasia in Patients with Mild to Moderate Essential Hypertension: A Double-Blind, Placebo-Controlled, Dose-Response Multicenter Study

Jay Y. Gillenwater, Richard Conn, Steven G. Chrysant et al. · The Journal of Urology · 1995 · 188 citations

, , +6

Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia

Hunter Wessells, Johnny Roy, John Bannow et al. · Urology · 2003 · 152 citations

, , +11

Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: Effects of finasteride

Joseph E. Oesterling, Johnny Roy, Arif H. Agha et al. · Urology · 1997 · 61 citations

, , +16

Proscar®: Five-Year Experience

E. Colleen Moore, Bruce Bracken, William J. Bremner et al. · European Urology · 1995 · 59 citations

1–5 of 7